Talking Points on Deprescribing in Hospice Care

Contents
Preface
About the Author
1. Introduction
2. Physiologic Changes of Terminal Illness
3. Fundamentals of Deprescribing
4. Deprescribing Statins
5. Deprescribing Benzodiazepines
6. Deprescribing Antipsychotics
7. Deprescribing SSRI and SNRI
8. Deprescribing Tricyclic Antidepressants
9. Deprescribing Anticholinergic Drugs for Parkinson’s Disease
10. Deprescribing Anticholinergic Drugs for Urinary Incontinence
11. Deprescribing Muscle Relaxants
12. Deprescribing Long-Term Opioids
13. Deprescribing Proton Pump Inhibitors
14. Deprescribing Urate-Lowering Agents
15. Deprescribing Hypoglycemics Oral Agents
16. Deprescribing Antihyperglycemics Injectable Agents (Insulins)
17. Deprescribing Antihypertensives
18. Deprescribing Anticoagulants
19. Deprescribing Cholinesterase Inhibitors
20. Deprescribing Glaucoma Eyedrops
21. Deprescribing Vitamin D andCalcium
22. Deprescribing NSAIDs
23. Deprescribing Gabapentin and Pregabalin
24. Deprescribing Long-Acting Beta Agonist and Other Inhalers
25. Deprescribing Vitamins, Minerals, and Nutritional Supplements
26. Deprescribing Medications in Children
27. Deprescribing in Subsets of LGBTQ Population
28. Cultural Competencies in Deprescribing
29. Chaplain and Medical Social Worker in Facilitating Deprescribing
30. When to Restart Discontinued Medications
31. Medicolegal Aspects of Deprescribing